Elutia (ELUT) Total Debt Growth (1y) (2020 - 2025)

Elutia (ELUT) Total Debt Growth (1y) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 157.11%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -12.26%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -1.95%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -2.48%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 0.12%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 19.06%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -5.76%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -2.49%
10 Elutia 39.99 Mn 11.50 Mn 1.80 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 15.29%
Jun 30, 2025 12.53%
Mar 31, 2025 10.22%
Dec 31, 2024 0.74%
Sep 30, 2024 -10.43%
Jun 30, 2024 -10.45%
Mar 31, 2024 -10.48%
Dec 31, 2023 -2.40%
Sep 30, 2023 26.39%
Jun 30, 2023 64.37%
Mar 31, 2023 46.22%
Dec 31, 2022 59.89%
Sep 30, 2022 -0.52%
Jun 30, 2022 -8.57%
Mar 31, 2022 -11.41%
Dec 31, 2021 -37.10%
Sep 30, 2021 -25.48%
Dec 31, 2020 1.18%